Patients with structural heart disease are at risk for life-threatening ventricular tachycardias (VTs). Implantable cardioverter-defibrillators (ICDs) can terminate VT, but often at the cost of ...

Please provide your email address to receive an email when new articles are posted on . Early published reports of cardioneural ablation have shown promise for the relief of autonomically mediated ...

Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Outcomes ...

The world's first remote heart procedure, using a robotic arm alongside 3-D mapping, is due to take place. It comes six months after the first ever remote catheter ablation procedure using the Amigo ...

For patients who require multisite venous access for catheter ablation procedures, the VASCADE MVP venous vascular closure system (Cardiva Medical) provides a variety of benefits, including a shorter ...

SAN FRANCISCO -- Noninvasive stereotactic radiotherapy (RT) for refractory ventricular tachycardia (VT) achieved outcomes similar to catheter ablation with substantially fewer serious adverse events ...

Earlier this year, I wrote (on DrJohnM and theheart.org) that catheter ablation of atrial fibrillation had become an easier journey. The short story is that AF ablation is a heck of lot easier now. In ...

A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and results in clinically important improvements ...

Stereotaxis announced that it has received European CE Mark approval for its MAGiC™ ablation catheter, marking a significant step in advancing robotic technology in electrophysiology. Designed for ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology ...

The world's first remote heart procedure, using a robotic arm alongside 3-D mapping, is due to take place at Glenfield Hospital in Leicester. It comes six months after Dr Andre Ng carried out the ...